Daily BriefsSouth Korea

Daily Brief South Korea: Aimed Bio and more

In today’s briefing:

  • A Review of Our IPO Calls in 2025


A Review of Our IPO Calls in 2025

By Douglas Kim

  • In this insight, we review our IPO calls in 2025. The accuracy rate of our calls on the IPOs this year was 64%. 
  • The overall sentiment on IPOs in Korea have improved in the second half of this year, paying the way for some completions of major IPOs in Korea in 2026.
  • LG CNS and Seoul Guarantee Insurance were two of the largest IPOs in Korea in 2025. Some of the best performing IPOs in Korea in 2025 include Nota and AimedBio.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars